News
Advarra Executive James Riddle Receives SRA International’s Best Concurrent Session Award
The Society of Research Administrators International (SRA International) has awarded James Riddle, Advarra VP of Institutional Services, its Best Concurrent Session Award.
Advarra Executive James Riddle Featured in IRB Advisor Article About FDA Guidance for COVID-19 and Clinical Trials
IRB Advisor interviewed James Riddle, Advarra VP of Institutional Services, for its article “FDA Releases Q&A for COVID-19 and Clinical Trials.”
Advarra Receives Full AAHRPP Reaccreditation Following First Remote Site Visit During Pandemic
The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has awarded the Advarra institutional review board (IRB) full reaccreditation.
Almac’s Spotlight on IRT Podcast Highlights Advarra Experts
In the latest episode of The Almac Group’s Spotlight on IRT podcast, Advarra Consulting experts Kathy Kelly and Ellen Liedel-Sargent were called on to discuss their perspectives on preparing interactive response technology (IRT) for regulatory inspections with host, Matt Lowrie.
Holiday Meeting Schedule – Civic Holiday (Canada)
Advarra’s Canadian offices will be closed on Monday, August 3.
New England Journal of Medicine Article Credits Advarra as IRB for mRNA Vaccine Trial
A recent NEJM article described Advarra’s involvement as the IRB of record for the phase I trial of the investigational mRNA-1273 vaccine. Read more:
Advarra Experts Featured in Almac Spotlight on IRT Podcast
Advarra Consulting’s Kathy Kelly and Ellen Liedel-Sargent were featured on The Almac Group’s Spotlight on IRT podcast.
PharmaVOICE Features Advarra CEO in “New Era of Clinical Trials” Cover Story
Gadi Saarony discusses how the research industry’s response to the COVID-19 pandemic will set the course for drug development for years to come.
Advarra Executive Michele Russell-Einhorn Featured in BBK Worldwide COVID-19 Response
Michele Russell-Einhorn, Advarra Chief Compliance Officer and Institutional Official addresses the research industry’s patient-centric response to COVID-19.
FDA Provides Free eConsent Platform for Eligible Clinical Trials During COVID-19
The FDA announced that its previously developed FDA MyStudies app is now available to investigators.
IRB Advisor Features Advarra Executive James Riddle in Article About Research Post-COVID-19
Riddle joins other experts in considering “how things will look when the COVID-19 pandemic has ended.”
Advarra Calls Research Sites “Unsung Heroes” of COVID-19 Crisis
In recognition of Clinical Trials Day, Advarra salutes sites and offers collaborative resources to restart research. Read more:
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.